AAAAAA
Results:
1-23
|
Results: 23
Authors:
Syme, RM
Bryan, TL
Gluck, S
Citation: Rm. Syme et al., Dendritic cell-based therapy: A review focusing on antigenic selection, J HEMATH ST, 10(5), 2001, pp. 601-608
Authors:
Syme, RM
Duggan, P
Stewart, D
Gluck, S
Citation: Rm. Syme et al., Generation of dendritic cells ex vivo: Differences in steady state versus mobilized blood from patients with breast cancer, with lymphoma, and from normal donors, J HEMATH ST, 10(5), 2001, pp. 621-630
Authors:
Syme, R
Gluck, S
Citation: R. Syme et S. Gluck, Effects of cytokines on the culture and differentiation of dendritic cellsin vitro, J HEMATH ST, 10(1), 2001, pp. 43-51
Authors:
Syme, R
Gluck, S
Citation: R. Syme et S. Gluck, Generation of dendritic cells: role of cytokines and potential clinical applications, TRANSF AP S, 24(2), 2001, pp. 117-124
Authors:
Eimuller, T
Fischer, P
Kohler, M
Scholz, M
Guttmann, P
Denbeaux, G
Gluck, S
Bayreuther, G
Schmahl, G
Attwood, D
Schutz, G
Citation: T. Eimuller et al., Transmission X-ray microscopy using X-ray magnetic circular dichroism, APPL PHYS A, 73(6), 2001, pp. 697-701
Authors:
Carlson, LE
Koski, T
Gluck, S
Citation: Le. Carlson et al., Longitudinal effects of high-dose chemotherapy and autologous stem cell transplantation on quality of life in the treatment of metastatic breast cancer, BONE MAR TR, 27(9), 2001, pp. 989-998
Authors:
Bewick, M
Conlon, M
Gerard, S
Lee, H
Parissenti, AM
Zhang, L
Gluck, S
Lafrenie, RM
Citation: M. Bewick et al., HER-2 expression is a prognostic factor in patients with metastatic breastcancer treated with a combination of high-dose cyclophosphamide, mitoxantrone, paclitaxel and autologous blood stem cell support, BONE MAR TR, 27(8), 2001, pp. 847-853
Authors:
Stewart, DA
Guo, D
Luider, J
Auer, I
Klassen, J
Morris, D
Brown, CB
Chaudhry, A
Gluck, S
Russell, JA
Citation: Da. Stewart et al., The CD3(-)16(+)56(+) NK cell count independently predicts autologous bloodstem cell mobilization, BONE MAR TR, 27(12), 2001, pp. 1237-1243
Authors:
Kassam, G
Kwon, M
Yoon, YS
Graham, KS
Young, MK
Gluck, S
Waisman, DM
Citation: G. Kassam et al., Purification and characterization of A(61) - An angiostatin-like plasminogen fragment produced by plasmin autodigestion in the absence of sulfhydryl donors, J BIOL CHEM, 276(12), 2001, pp. 8924-8933
Authors:
Rock, G
Chin-Yee, I
Cantin, G
Giulivi, A
Gluck, S
Keating, A
Keeny, M
Klassen, J
Sutherland, R
Citation: G. Rock et al., Quality assurance of progenitor cell content of apheresis products: a comparison of clonogenic assays and CD34+enumeration, TRANSFUS M, 10(1), 2000, pp. 67-75
Authors:
Schimmer, AD
Jamal, S
Messner, H
Keating, A
Meharchand, J
Huebsch, L
Walker, I
Benger, A
Gluck, S
Smith, A
Citation: Ad. Schimmer et al., Allogeneic or autologous bone marrow transplantation (BMT) for non-Hodgkin's lymphoma (NHL): results of a provincial strategy, BONE MAR TR, 26(8), 2000, pp. 859-864
Authors:
Stewart, DA
Guo, D
Gluck, S
Morris, D
Chaudhry, A
deMetz, C
Klassen, J
Brown, CB
Russell, JA
Citation: Da. Stewart et al., Double high-dose therapy for Hodgkin's disease with dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP) prior to high-dose melphalan and autologous stem cell transplantation, BONE MAR TR, 26(4), 2000, pp. 383-388
Authors:
Duggan, PR
Guo, D
Luider, J
Auer, I
Klassen, J
Chaudhry, A
Morris, D
Gluck, S
Brown, CB
Russell, JA
Stewart, DA
Citation: Pr. Duggan et al., Predictive factors for long-term engraftment of autologous blood stem cells, BONE MAR TR, 26(12), 2000, pp. 1299-1304
Authors:
Stewart, DA
Guo, D
Luider, J
Auer, I
Klassen, J
Morris, D
Chaudhry, A
Brown, C
Russell, JA
Gluck, S
Citation: Da. Stewart et al., The CD34(+)90(+) cell dose does not predict early engraftment of autologous blood stem cells as well as the total CD34(+) cell dose, BONE MAR TR, 25(4), 2000, pp. 435-440
Authors:
Gluck, S
Stewart, D
Citation: S. Gluck et D. Stewart, High-dose therapy in breast cancer: out of favor but not out of promise, BONE MAR TR, 25(10), 2000, pp. 1017-1019
Authors:
Chadderton, A
Villeneuve, DJ
Gluck, S
Kirwan-Rhude, AF
Gannon, BR
Blais, DE
Parissenti, AM
Citation: A. Chadderton et al., Role of specific apoptotic pathways in the restoration of paclitaxel-induced apoptosis by valspodar in doxorubicin-resistant MCF-7 breast cancer cells, BREAST CANC, 59(3), 2000, pp. 231-244
Authors:
Gluck, S
Citation: S. Gluck, Ex vivo expansion of hematopoietic stem cells, J HEMATH ST, 8(6), 1999, pp. 575-575
Authors:
Goss, P
Stewart, AK
Couture, F
Klasa, R
Gluck, S
Kaizer, L
Burkes, R
Charpentier, D
Palmer, M
Tye, L
Dulude, H
Citation: P. Goss et al., Combined results of two phase II studies of Taxol (R) (paclitaxel) in patients with relapsed or refractory lymphomas, LEUK LYMPH, 34(3-4), 1999, pp. 295-304
Authors:
Gluck, S
Stewart, D
Citation: S. Gluck et D. Stewart, What's happening? Current status of high dose chemotherapy in breast cancer, TRANSFUS SC, 21(3), 1999, pp. 211-214
Authors:
Theriault, RL
Lipton, A
Hortobagyi, GN
Leff, R
Gluck, S
Stewart, JF
Costello, S
Kennedy, I
Simeone, J
Seaman, JJ
Knight, RD
Mellars, K
Heffernan, M
Reitsma, DJ
Citation: Rl. Theriault et al., Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: A randomized, placebo-controlled trial, J CL ONCOL, 17(3), 1999, pp. 846-854
Authors:
Bewick, M
Chadderton, T
Conlon, M
Lafrenie, R
Morris, D
Stewart, D
Gluck, S
Citation: M. Bewick et al., Expression of C-erbB-2/HER-2 in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous blood stem cell support, BONE MAR TR, 24(4), 1999, pp. 377-384
Authors:
Parissenti, AM
Gannon, BR
Villeneuve, DJ
Kirwan-Rhude, AF
Chadderton, A
Gluck, S
Citation: Am. Parissenti et al., Lack of modulation of MDR1 gene expression by dominant inhibition of cAMP-dependent protein kinase in doxorubicin-resistant MCF-7 breast cancer cells, INT J CANC, 82(6), 1999, pp. 893-900
Authors:
Sorel, M
Gluck, S
Laybourn, PJR
Citation: M. Sorel et al., Semiconductor double ring waveguide resonators, ELECTR LETT, 35(18), 1999, pp. 1551-1552
Risultati:
1-23
|